July 24 (Reuters) – A panel of outside advisers to the U.S. FDA on Friday voted to exclude peptide emideltide from a list that would allow broader pharmacy compounding. Seven members voted against recommending emideltide to be on the list, while six members voted in favor. One member abstained. (Rep
July 24 (Reuters) – The number of people confirmed infected with Ebola in the Democratic Republic of Congo was heading towards 3,000 on Friday after officials reviewed data in two of the worst-hit provinces and reported more than 300 new cases. • The number of confirmed Ebola cases was 2,905, includ
By Sriparna Roy, Sneha S K and Amina Niasse July 24 (Reuters) – Outside advisers to the U.S. Food and Drug Administration recommended broader access to six unapproved peptides, capping a two-day review that backed most of the compounds despite the health regulator’s staff concerns about limited safe
July 24 (Reuters) – Amgen said on Friday it submitted new evidence to the FDA on July 23 as it seeks a hearing to challenge the proposed withdrawal of its rare-disease drug Tavneos from the U.S. market. The U.S. Food and Drug Administration in April proposed withdrawing the drug, which treats a rare
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays) By Nancy Lapid July 23 (Reuters) – We also report on new insights into the skin-discoloring disorder vitiligo that may someday lead to corrective treatments. EXPERIMENTAL GLP-1 COM
By Christy Santhosh July 24 (Reuters) – Merck said on Friday it signed seven voluntary licensing agreements with generic drug manufacturers to make and sell lower-cost versions of its experimental once-monthly oral HIV pill in 129 low- and lower-middle-income countries. The drug, alimatravir, is cur
By Rishika Sadam and Vivek Kumar M July 24 (Reuters) – India’s Manipal Health Enterprises plans to spend 40 billion rupees ($414.38 million) to increase its bed capacity by over 18% in the next few years, a company executive said on Friday, ahead of the launch of the hospital chain operator’s IPO ne
(Corrects name of rare neurological disorder, to ATTRv-PN, in paragraph 9) By Maggie Fick LONDON, July 24 (Reuters) – AstraZeneca’s long-time CEO Pascal Soriot has rarely put a foot wrong. The company’s shares have more that quadrupled in price during his 14-year tenure, soaring above the wider FTSE
By Richa Naidu VEVEY, Switzerland, July 24 (Reuters) – As shoppers increasingly scrutinise ingredient labels to avoid products perceived as heavily processed, Nestle, maker of Nescafe coffee and KitKat chocolate, has been lobbying U.S. authorities to allow simpler descriptions using common rather th
DEIR AL-BALAH, Gaza Strip (AP) — The world’s leading authority on food insecurity said Thursday that the situation in Gaza had improved since famine was declared in parts of the Palestinian territory last year, but warned that conditions are still at crisis levels. The Integrated Food Security Phase
MEXICO CITY, July 23 (Reuters) – Mexico’s health ministry said on Thursday that results of its studies of lettuce and water samples from U.S. supplier Taylor Farms were negative for cyclospora, following a health inspection and the company’s plant in central Mexico earlier this week. “The analysis u
July 23 (Reuters) – A panel of advisers to the U.S. Food and Drug Administration on Thursday voted to place a popular peptide called TB-500 on a list that would allow broader pharmacy compounding. Eight panel members voted in favor, while six voted against. One member abstained. The FDA is not bound
July 23 (Reuters) – Edwards Lifesciences beat analysts’ estimates for second-quarter profit and revenue on Thursday, helped by strong demand for its artificial heart valves used in complex cardiac procedures, sending its shares up nearly 7% in extended trading. Medical technology firms are seeing in
July 23 (Reuters) – GE HealthCare’s Chief Financial Officer Jay Saccaro will step down from his role to pursue an opportunity outside the medical technology industry, the company said on Thursday, and also reported preliminary second-quarter results. The medical device maker named its current contro
Some Democrats are squaring off with President Donald Trump’s administration over one of the most potent political issues in the country ahead of this year’s midterm elections: Social Security. The social safety net program that financially supports more than 70 million people — mostly retirees but
NEW YORK (AP) — The Senate health committee delayed a planned vote Thursday on whether to advance the nomination of Dr. Erica Schwartz to lead the U.S. Centers for Disease Control and Prevention. The committee plans to vote next week on whether to forward Schwartz’s nomination to the full Senate. Th
Federal health officials are investigating a new outbreak involving the diarrhea-causing parasite cyclospora. The outbreak included 72 people as of Wednesday. The Food and Drug Administration has not yet identified which products are linked to the illnesses. Officials also have not said where the ca
ABUJA, Nigeria (AP) — The Ebola outbreak in Congo has killed over 1,000 people, reaching the grim milestone nearly three times faster than the 2014-2016 Ebola epidemic that is considered the worst on record. Data from Congo’s Ministry of Health shows that as of Tuesday, the current outbreak, declare
July 23 (Reuters) – A panel of advisers to the U.S. Food and Drug Administration on Thursday voted to place a widely used peptide called BPC-157 on a list that would allow broader pharmacy compounding. Eight panel members voted in favor, while six members voted against it. One member abstained. (Rep
By Sriparna Roy, Amina Niasse and Sneha S K July 23 (Reuters) – A majority of the U.S. Food and Drug Administration’s panel of outside advisers on Thursday voted to allow pharmacies to compound the first of seven in its review of widely used peptides, the increasingly popular compounded medicines ba
July 23 (Reuters) – Taylor Farms has temporarily shut down the Central Mexico processing facility that U.S. health officials have linked to an ongoing multi-state cyclosporiasis outbreak, an industry source familiar with the matter said on Thursday. The facility produces 5-pound bags of shredded ice
July 23 (Reuters) – Quest Diagnostics on Thursday raised its full-year profit forecast, after demand for routine diagnostic testing helped the company beat second-quarter estimates. Shares of the New Jersey-based company rose about 5% in premarket trading following the results. Here are the details
By Amina Niasse NEW YORK, July 23 (Reuters) – Health insurer Cigna said on Thursday that the artificial intelligence tools it is employing to identify patients with chronic or complex conditions will save customers $200 million in medical costs over the next three years. Bryan Holgerson, a president
BEIJING, July 23 (Reuters) – BeOne Medicines announced on Thursday an additional $300 million investment to a manufacturing and R&D facility in New Jersey, bringing total U.S. manufacturing investment to more than $1 billion, it said in a statement. “The expansion will increase BeOne’s production ca
BUDAPEST, July 23 (Reuters) – Hungary’s government will scrap a 5% value-added tax on subscription drugs from September 1, which will cost the budget 7 billion forints ($21.93 million), Prime Minister Peter Magyar said on Thursday. The government is also planning to cut the value-added tax on wood u
By Deena Beasley July 23 (Reuters) – Eli Lilly said on Thursday that two more Phase 3 trials of its experimental obesity drug retatrutide showed positive results and it plans to submit an application to the U.S. Food and Drug Administration in the first quarter of next year. Retatrutide is designed
By Siddhi Mahatole July 23 (Reuters) – West Pharmaceutical Services raised its annual profit and revenue forecasts on Thursday as strong demand for components used in injectable drugs, including diabetes and obesity treatments, helped it beat second-quarter estimates. Shares of the medical equipment
By Puyaan Singh and Kunal Das July 23 (Reuters) – Thermo Fisher Scientific raised its annual profit forecast after beating Wall Street estimates for second-quarter results on Thursday, as improving customer demand lifted sales across all its business segments, sending shares up 10%. The life science
By Christy Santhosh July 23 (Reuters) – Shares of health insurer Molina Healthcare fell 9% in premarket trading on Thursday as concerns about the company’s Obamacare and Medicaid businesses weighed on its second-quarter results. The company late on Wednesday posted quarterly profit and revenue that
By Amina Niasse July 23 – Hims & Hers Health is set to tap what analysts estimate could be a multi-billion-dollar market for peptides if U.S. regulators loosen manufacturing restrictions. Hims, primarily known for its personalized treatments of conditions ranging from hair loss to acne, is eyeing pe
